Thyroid hormone receptors and cancer

Biochimica et Biophysica Acta - General Subjects

Volumn 1830, Issue 7, 2013, Pages 3928-3936

  Kim, Won Gu ^a   Cheng, Sheue Yann ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Catenin; Mouse model; Phosphatidylinositol 3 kinase; Src kinase; Thyroid cancer; Thyroid hormone receptor mutant

Indexed keywords

BETA CATENIN; FOCAL ADHESION KINASE; INTEGRIN; LIOTHYRONINE; MAMMALIAN TARGET OF RAPAMYCIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; PIOGLITAZONE; PROTEIN TYROSINE KINASE; SECURIN; THYROID HORMONE RECEPTOR; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR BETA; THYROTROPIN;

CANCER GROWTH; CARCINOGENESIS; DOWN REGULATION; GAIN OF FUNCTION MUTATION; GENE DELETION; GENE REPRESSION; GENETIC ASSOCIATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LOSS OF FUNCTION MUTATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SOMATIC MUTATION; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS; RECEPTORS, THYROID HORMONE; SIGNAL TRANSDUCTION; THYROID HORMONES;

MUS;

EID: 84877581834     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2012.04.002     Document Type: Review

References (97)

1. C. Weinberger, C.C. Thompson, E.S. Ong, R. Lebo, D.J. Gruol, and R.M. Evans The c-erb-A gene encodes a thyroid hormone receptor Nature 324 1986 641 646
2. J. Sap, A. Munoz, K. Damm, Y. Goldberg, J. Ghysdael, A. Leutz, H. Beug, and B. Vennstrom The c-erb-A protein is a high-affinity receptor for thyroid hormone Nature 324 1986 635 640
3. R.L. Wagner, J.W. Apriletti, M.E. McGrath, B.L. West, J.D. Baxter, and R.J. Fletterick A structural role for hormone in the thyroid hormone receptor Nature 378 1995 690 697
4. R.L. Wagner, B.R. Huber, A.K. Shiau, A. Kelly, S.T. Cunha Lima, T.S. Scanlan, J.W. Apriletti, J.D. Baxter, B.L. West, and R.J. Fletterick Hormone selectivity in thyroid hormone receptors Mol. Endocrinol. 15 2001 398 410
5. S.Y. Cheng, J.L. Leonard, and P.J. Davis Molecular aspects of thyroid hormone actions Endocr. Rev. 31 2010 139 170
6. T. Alenghat, K. Meyers, S.E. Mullican, K. Leitner, A. Adeniji-Adele, J. Avila, M. Bucan, R.S. Ahima, K.H. Kaestner, and M.A. Lazar Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology Nature 456 2008 997 1000
7. I. Astapova, L.J. Lee, C. Morales, S. Tauber, M. Bilban, and A.N. Hollenberg The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo Proc. Natl. Acad. Sci. U. S. A. 105 2008 19544 19549
8. I. Astapova, K.R. Vella, P. Ramadoss, K.A. Holtz, B.A. Rodwin, X.H. Liao, R.E. Weiss, M.A. Rosenberg, A. Rosenzweig, and A.N. Hollenberg The nuclear receptor corepressor (NCoR) controls thyroid hormone sensitivity and the set point of the hypothalamic-pituitary-thyroid axis Mol. Endocrinol. 25 2011 212 224
9. D. Thormeyer, and A. Baniahmad The v-erbA oncogene (review) Int. J. Mol. Med. 4 1999 351 358
10. P.M. Yen, M. Ikeda, J.H. Brubaker, M. Forgione, A. Sugawara, and W.W. Chin Roles of v-erbA homodimers and heterodimers in mediating dominant negative activity by v-erbA J. Biol. Chem. 269 1994 903 909
11. H.W. Chen, and M.L. Privalsky The erbA oncogene represses the actions of both retinoid X and retinoid A receptors but does so by distinct mechanisms Mol. Cell. Biol. 13 1993 5970 5980
12. C. Barlow, B. Meister, M. Lardelli, U. Lendahl, and B. Vennstrom Thyroid abnormalities and hepatocellular carcinoma in mice transgenic for v-erbA EMBO J. 13 1994 4241 4250
13. F. Leduc, H. Brauch, C. Hajj, A. Dobrovic, F. Kaye, A. Gazdar, J.W. Harbour, O.S. Pettengill, G.D. Sorenson, and A. van den Berg Loss of heterozygosity in a gene coding for a thyroid hormone receptor in lung cancers Am. J. Hum. Genet. 44 1989 282 287
14. K. Sisley, D. Curtis, I.G. Rennie, and R.C. Rees Loss of heterozygosity of the thyroid hormone receptor B in posterior uveal melanoma Melanoma Res. 3 1993 457 461
15. L.C. Chen, K. Matsumura, G. Deng, W. Kurisu, B.M. Ljung, M.I. Lerman, F.M. Waldman, and H.S. Smith Deletion of two separate regions on chromosome 3p in breast cancers Cancer Res. 54 1994 3021 3024
16. J.M. Gonzalez-Sancho, V. Garcia, F. Bonilla, and A. Munoz Thyroid hormone receptors/THR genes in human cancer Cancer Lett. 192 2003 121 132
17. T. Huber-Gieseke, A. Pernin, O. Huber, A.G. Burger, and C.A. Meier Lack of loss of heterozygosity at the c-erbA beta locus in gastrointestinal tumors Oncology 54 1997 214 219
18. I.U. Ali, R. Lidereau, and R. Callahan Presence of two members of c-erbA receptor gene family (c-erbA beta and c-erbA2) in smallest region of somatic homozygosity on chromosome 3p21-p25 in human breast carcinoma J. Natl. Cancer Inst. 81 1989 1815 1820
19. P.A. Futreal, P. Soderkvist, J.R. Marks, J.D. Iglehart, C. Cochran, J.C. Barrett, and R.W. Wiseman Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms Cancer Res. 52 1992 2624 2627
20. J. Yokota, T. Yamamoto, N. Miyajima, K. Toyoshima, N. Nomura, H. Sakamoto, T. Yoshida, M. Terada, and T. Sugimura Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue Oncogene 2 1988 283 287
21. A.I. Dayton, J.R. Selden, G. Laws, D.J. Dorney, J. Finan, P. Tripputi, B.S. Emanuel, G. Rovera, P.C. Nowell, and C.M. Croce A human c-erbA oncogene homologue is closely proximal to the chromosome 17 breakpoint in acute promyelocytic leukemia Proc. Natl. Acad. Sci. U. S. A. 81 1984 4495 4499
22. K.H. Lin, H.Y. Shieh, S.L. Chen, and H.C. Hsu Expression of mutant thyroid hormone nuclear receptors in human hepatocellular carcinoma cells Mol. Carcinog. 26 1999 53 61
23. M. Puzianowska-Kuznicka, A. Nauman, A. Madej, Z. Tanski, S. Cheng, and J. Nauman Expression of thyroid hormone receptors is disturbed in human renal clear cell carcinoma Cancer Lett. 155 2000 145 152
24. Y. Kamiya, M. Puzianowska-Kuznicka, P. McPhie, J. Nauman, S.Y. Cheng, and A. Nauman Expression of mutant thyroid hormone nuclear receptors is associated with human renal clear cell carcinoma Carcinogenesis 23 2002 25 33
25. J.M. Silva, G. Dominguez, J.M. Gonzalez-Sancho, J.M. Garcia, J. Silva, C. Garcia-Andrade, A. Navarro, A. Munoz, and F. Bonilla Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer Oncogene 21 2002 4307 4316
26. J.D. Safer, S.D. Colan, L.M. Fraser, and F.E. Wondisford A pituitary tumor in a patient with thyroid hormone resistance: a diagnostic dilemma Thyroid 11 2001 281 291
27. S. Ando, N.J. Sarlis, E.H. Oldfield, and P.M. Yen Somatic mutation of TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor J. Clin. Endocrinol. Metab. 86 2001 5572 5576
28. M. Puzianowska-Kuznicka, A. Krystyniak, A. Madej, S.Y. Cheng, and J. Nauman Functionally impaired TR mutants are present in thyroid papillary cancer J. Clin. Endocrinol. Metab. 87 2002 1120 1128
29. B. Joseph, M. Ji, D. Liu, P. Hou, and M. Xing Lack of mutations in the thyroid hormone receptor (TR) alpha and beta genes but frequent hypermethylation of the TRbeta gene in differentiated thyroid tumors J. Clin. Endocrinol. Metab. 92 2007 4766 4770
30. Y. Ling, X. Xu, J. Hao, X. Ling, X. Du, X. Liu, and X. Zhao Aberrant methylation of the THRB gene in tissue and plasma of breast cancer patients Cancer Genet. Cytogenet. 196 2010 140 145
31. Y. Iwasaki, N. Sunaga, Y. Tomizawa, H. Imai, H. Iijima, N. Yanagitani, K. Horiguchi, M. Yamada, and M. Mori Epigenetic inactivation of the thyroid hormone receptor beta1 gene at 3p24.2 in lung cancer Ann. Surg. Oncol. 17 2010 2222 2228
32. Z. Li, Z.H. Meng, R. Chandrasekaran, W.L. Kuo, C.C. Collins, J.W. Gray, and S.H. Dairkee Biallelic inactivation of the thyroid hormone receptor beta1 gene in early stage breast cancer Cancer Res. 62 2002 1939 1943
33. K. Jazdzewski, J. Boguslawska, J. Jendrzejewski, S. Liyanarachchi, J. Pachucki, K.A. Wardyn, A. Nauman, and A. de la Chapelle Thyroid hormone receptor beta (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC) J. Clin. Endocrinol. Metab. 96 2011 E546 E553
34. M. Kaneshige, K. Kaneshige, X. Zhu, A. Dace, L. Garrett, T.A. Carter, R. Kazlauskaite, D.G. Pankratz, A. Wynshaw-Boris, S. Refetoff, B. Weintraub, M.C. Willingham, C. Barlow, and S. Cheng Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone Proc. Natl. Acad. Sci. U. S. A. 97 2000 13209 13214
35. R. Parrilla, A.J. Mixson, J.A. McPherson, J.H. McClaskey, and B.D. Weintraub Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain J. Clin. Invest. 88 1991 2123 2130
36. H. Suzuki, M.C. Willingham, and S.Y. Cheng Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis Thyroid 12 2002 963 969
37. H. Ying, H. Suzuki, L. Zhao, M.C. Willingham, P. Meltzer, and S.Y. Cheng Mutant thyroid hormone receptor beta represses the expression and transcriptional activity of peroxisome proliferator-activated receptor gamma during thyroid carcinogenesis Cancer Res. 63 2003 5274 5280
38. Y. Kato, H. Ying, M.C. Willingham, and S.Y. Cheng A tumor suppressor role for thyroid hormone beta receptor in a mouse model of thyroid carcinogenesis Endocrinology 145 2004 4430 4438
39. D. Forrest, L.C. Erway, L. Ng, R. Altschuler, and T. Curran Thyroid hormone receptor beta is essential for development of auditory function Nat. Genet. 13 1996 354 357
40. L. Wikstrom, C. Johansson, C. Salto, C. Barlow, A. Campos Barros, F. Baas, D. Forrest, P. Thoren, and B. Vennstrom Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor alpha 1 EMBO J. 17 1998 455 461
41. D. Forrest, and B. Vennstrom Functions of thyroid hormone receptors in mice Thyroid 10 2000 41 52
42. X.G. Zhu, L. Zhao, M.C. Willingham, and S.Y. Cheng Thyroid hormone receptors are tumor suppressors in a mouse model of metastatic follicular thyroid carcinoma Oncogene 29 2010 1909 1919
43. H. Ying, H. Suzuki, H. Furumoto, R. Walker, P. Meltzer, M.C. Willingham, and S.Y. Cheng Alterations in genomic profiles during tumor progression in a mouse model of follicular thyroid carcinoma Carcinogenesis 24 2003 1467 1479
44. S.Y. Cheng Multi-factorial regulation of in vivo action of TR beta mutants. Lessons learned from RTH mice with a targeted mutation in the TR beta gene S.E. Mannavola, Syndromes of Hormone Resistance in the Hypothalamic- Pituitary-Thyroid Axis 2004 Kluwer The Netherlands 137 148
45. S.Y. Cheng New developments in thyroid hormone resistance Hot Thyroidol. 1 January 2004 (www.hotthyroidology.com)
46. T.G. Kroll, P. Sarraf, L. Pecciarini, C.J. Chen, E. Mueller, B.M. Spiegelman, and J.A. Fletcher PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected] Science 289 2000 1357 1360
47. Y. Kato, H. Ying, L. Zhao, F. Furuya, O. Araki, M.C. Willingham, and S.Y. Cheng PPARgamma insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-kappaB signaling pathway Oncogene 25 2006 2736 2747
48. M.E. Dobson, E. Diallo-Krou, V. Grachtchouk, J. Yu, L.A. Colby, J.E. Wilkinson, T.J. Giordano, and R.J. Koenig Pioglitazone induces a proadipogenic antitumor response in mice with PAX8-PPARgamma fusion protein thyroid carcinoma Endocrinology 152 2011 4455 4465
49. T. Simoncini, A. Hafezi-Moghadam, D.P. Brazil, K. Ley, W.W. Chin, and J.K. Liao Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase Nature 407 2000 538 541
50. Y. Hiroi, H.H. Kim, H. Ying, F. Furuya, Z. Huang, T. Simoncini, K. Noma, K. Ueki, N.H. Nguyen, T.S. Scanlan, M.A. Moskowitz, S.Y. Cheng, and J.K. Liao Rapid nongenomic actions of thyroid hormone Proc. Natl. Acad. Sci. U. S. A. 103 2006 14104 14109
51. X. Cao, F. Kambe, L.C. Moeller, S. Refetoff, and H. Seo Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts Mol. Endocrinol. 19 2005 102 112
52. A. Kenessey, and K. Ojamaa Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways J. Biol. Chem. 281 2006 20666 20672
53. N.M. Storey, S. Gentile, H. Ullah, A. Russo, M. Muessel, C. Erxleben, and D.L. Armstrong Rapid signaling at the plasma membrane by a nuclear receptor for thyroid hormone Proc. Natl. Acad. Sci. U. S. A. 103 2006 5197 5201
54. C. Verga Falzacappa, L. Panacchia, B. Bucci, A. Stigliano, M.G. Cavallo, E. Brunetti, V. Toscano, and S. Misiti 3,5,3′-Triiodothyronine (T3) is a survival factor for pancreatic beta-cells undergoing apoptosis J. Cell. Physiol. 206 2006 309 321
55. C. Verga Falzacappa, E. Petrucci, V. Patriarca, S. Michienzi, A. Stigliano, E. Brunetti, V. Toscano, and S. Misiti Thyroid hormone receptor TRbeta1 mediates Akt activation by T3 in pancreatic beta cells J. Mol. Endocrinol. 38 2007 221 233
56. M.D. Ringel, N. Hayre, J. Saito, B. Saunier, F. Schuppert, H. Burch, V. Bernet, K.D. Burman, L.D. Kohn, and M. Saji Overexpression and overactivation of Akt in thyroid carcinoma Cancer Res. 61 2001 6105 6111
57. M. Miyakawa, T. Tsushima, H. Murakami, K. Wakai, O. Isozaki, and K. Takano Increased expression of phosphorylated p70S6 kinase and Akt in papillary thyroid cancer tissues Endocr. J. 50 2003 77 83
58. P. Mellor, L.A. Furber, J.N. Nyarko, and D.H. Anderson Multiple roles for the p85alpha isoform in the regulation and function of PI3K signalling and receptor trafficking Biochem. J. 441 2012 23 37
59. C.S. Kim, V.V. Vasko, Y. Kato, M. Kruhlak, M. Saji, S.Y. Cheng, and M.D. Ringel AKT activation promotes metastasis in a mouse model of follicular thyroid carcinoma Endocrinology 146 2005 4456 4463
60. F. Furuya, J.A. Hanover, and S.Y. Cheng Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor Proc. Natl. Acad. Sci. U. S. A. 103 2006 1780 1785
61. F. Furuya, C.J. Guigon, L. Zhao, C. Lu, J.A. Hanover, and S.Y. Cheng Nuclear receptor corepressor is a novel regulator of phosphatidylinositol 3-kinase signaling Mol. Cell. Biol. 27 2007 6116 6126
62. F. Furuya, C. Lu, M.C. Willingham, and S.Y. Cheng Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer Carcinogenesis 28 2007 2451 2458
63. C.J. Guigon, L. Zhao, M.C. Willingham, and S.Y. Cheng PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer Oncogene 28 2009 509 517
64. S.K. Mitra, and D.D. Schlaepfer Integrin-regulated FAK-Src signaling in normal and cancer cells Curr. Opin. Cell Biol. 18 2006 516 523
65. M.P. Playford, and M.D. Schaller The interplay between Src and integrins in normal and tumor biology Oncogene 23 2004 7928 7946
66. T. Dahlman, L. Grimelius, G. Wallin, K. Rubin, and K. Westermark Integrins in thyroid tissue: upregulation of alpha2beta1 in anaplastic thyroid carcinoma Eur. J. Endocrinol. 138 1998 104 112
67. C. Ensinger, P. Obrist, C. Bacher-Stier, G. Mikuz, R. Moncayo, and G. Riccabona Beta 1-integrin expression in papillary thyroid carcinoma Anticancer Res. 18 1998 33 40
68. L.V. Owens, L. Xu, G.A. Dent, X. Yang, G.C. Sturge, R.J. Craven, and W.G. Cance Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer Ann. Surg. Oncol. 3 1996 100 105
69. S.J. Kim, J.W. Park, J.S. Yoon, J.O. Mok, Y.J. Kim, H.K. Park, C.H. Kim, D.W. Byun, Y.J. Lee, S.Y. Jin, K.I. Suh, and M.H. Yoo Increased expression of focal adhesion kinase in thyroid cancer: immunohistochemical study J. Korean Med. Sci. 19 2004 710 715
70. C. Michailidi, C. Giaginis, V. Stolakis, P. Alexandrou, J. Klijanienko, I. Delladetsima, N. Chatzizacharias, G. Tsourouflis, and S. Theocharis Evaluation of FAK and Src expression in human benign and malignant thyroid lesions Pathol. Oncol. Res. 16 2010 497 507
71. C. Lu, L. Zhao, H. Ying, M.C. Willingham, and S.Y. Cheng Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma Endocrinology 151 2010 1929 1939
72. A. Angers-Loustau, R. Hering, T.E. Werbowetski, D.R. Kaplan, and R.F. Del Maestro SRC regulates actin dynamics and invasion of malignant glial cells in three dimensions Mol. Cancer Res. 2 2004 595 605
73. E. Avizienyte, M. Keppler, E. Sandilands, V.G. Brunton, S.J. Winder, T. Ng, and M.C. Frame An active Src kinase-beta-actin association is linked to actin dynamics at the periphery of colon cancer cells Exp. Cell Res. 313 2007 3175 3188
74. S.K. Mitra, D.A. Hanson, and D.D. Schlaepfer Focal adhesion kinase: in command and control of cell motility Nat. Rev. Mol. Cell Biol. 6 2005 56 68
75. W.G. Kim, C.J. Guigon, L. Fozzatti, J.W. Park, C. Lu, M.C. Willingham, and S.Y. Cheng SKI-606, a Src inhibitor, reduces tumor growth, invasion, and distant metastasis in a mouse model of thyroid cancer Clin. Cancer Res. 18 2012 1281 1290
76. R. Yu, and S. Melmed Oncogene activation in pituitary tumors Brain Pathol. 11 2001 328 341
77. L. Pei, and S. Melmed Isolation and characterization of a pituitary tumor-transforming gene (PTTG) Mol. Endocrinol. 11 1997 433 441
78. R. Yu, A.P. Heaney, W. Lu, J. Chen, and S. Melmed Pituitary tumor transforming gene causes aneuploidy and p53-dependent and p53-independent apoptosis J. Biol. Chem. 275 2000 36502 36505
79. R. Yu, W. Lu, J. Chen, C.J. McCabe, and S. Melmed Overexpressed pituitary tumor-transforming gene causes aneuploidy in live human cells Endocrinology 144 2003 4991 4998
80. D. Kim, H. Pemberton, A.L. Stratford, K. Buelaert, J.C. Watkinson, V. Lopes, J.A. Franklyn, and C.J. McCabe Pituitary tumour transforming gene (PTTG) induces genetic instability in thyroid cells Oncogene 24 2005 4861 4866
81. A.P. Heaney, V. Nelson, M. Fernando, and G. Horwitz Transforming events in thyroid tumorigenesis and their association with follicular lesions J. Clin. Endocrinol. Metab. 86 2001 5025 5032
82. D.S. Kim, C.J. McCabe, M.A. Buchanan, and J.C. Watkinson Oncogenes in thyroid cancer Clin. Otolaryngol. Allied Sci. 28 2003 386 395
83. D.B. Zimonjic, Y. Kato, H. Ying, N.C. Popescu, and S.Y. Cheng Chromosomal aberrations in cell lines derived from thyroid tumors spontaneously developed in TRbetaPV/PV mice Cancer Genet. Cytogenet. 161 2005 104 109
84. H. Ying, F. Furuya, L. Zhao, O. Araki, B.L. West, J.A. Hanover, M.C. Willingham, and S.Y. Cheng Aberrant accumulation of PTTG1 induced by a mutated thyroid hormone beta receptor inhibits mitotic progression J. Clin. Invest. 116 2006 2972 2984
85. A. Dace, L. Zhao, K.S. Park, T. Furuno, N. Takamura, M. Nakanishi, B.L. West, J.A. Hanover, and S. Cheng Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors Proc. Natl. Acad. Sci. U. S. A. 97 2000 8985 8990
86. P. Polakis The many ways of Wnt in cancer Curr. Opin. Genet. Dev. 17 2007 45 51
87. P. Polakis Casein kinase 1: a Wnt'er of disconnect Curr. Biol. 12 2002 R499 R501
88. J. Liu, J. Stevens, C.A. Rote, H.J. Yost, Y. Hu, K.L. Neufeld, R.L. White, and N. Matsunami Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein Mol. Cell 7 2001 927 936
89. G. Garcia-Rostan, G. Tallini, A. Herrero, T.G. D'Aquila, M.L. Carcangiu, and D.L. Rimm Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma Cancer Res. 59 1999 1811 1815
90. C.J. Guigon, L. Zhao, C. Lu, M.C. Willingham, and S.Y. Cheng Regulation of beta-catenin by a novel nongenomic action of thyroid hormone beta receptor Mol. Cell. Biol. 28 2008 4598 4608
91. H. Furumoto, H. Ying, G.V. Chandramouli, L. Zhao, R.L. Walker, P.S. Meltzer, M.C. Willingham, and S.Y. Cheng An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis Mol. Cell. Biol. 25 2005 124 135
92. C. Lu, A. Mishra, Y.J. Zhu, P. Meltzer, and S.Y. Cheng Global expression profiling reveals gain-of-function oncogenic activity of a mutated thyroid hormone receptor in thyroid carcinogenesis Am. J. Cancer Res. 1 2011 168 191
93. C.J. Guigon, and S.Y. Cheng Novel oncogenic actions of TRbeta mutants in tumorigenesis IUBMB Life 61 2009 528 536
94. C.J. Guigon, and S.Y. Cheng Novel non-genomic signaling of thyroid hormone receptors in thyroid carcinogenesis Mol. Cell. Endocrinol. 308 2009 63 69
95. C. Lu, and S.Y. Cheng Extranuclear signaling of mutated thyroid hormone receptors in promoting metastatic spread in thyroid carcinogenesis Steroids 76 2011 885 891
96. C.S. Kim, H. Ying, M.C. Willingham, and S.Y. Cheng The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer Carcinogenesis 28 2007 932 939
97. C.J. Guigon, D.W. Kim, M.C. Willingham, and S.Y. Cheng Mutation of thyroid hormone receptor-beta in mice predisposes to the development of mammary tumors Oncogene 30 2011 3381 3390